GEN Exclusives

More »

GEN News Highlights

More »
Apr 24, 2012

Novo Nordisk, Kennedy Institute Partner on Rheumatoid Arthritis Drug and Biomarker R&D

  • Novo Nordisk is partnering with Oxford University’s Kennedy Institute of Rheumatology in the U.K. for the discovery and development of new biomarkers and drug targets for rheumatoid arthritis and other inflammatory autoimmune diseases. Under terms of the agreement, Novo Nordisk will fund 10 researchers at the Kennedy Institute to work within the partnership.

    The Institute has in the past made key discoveries in the field of rheumatoid arthritis pathobiology, and its head, professor Sir Marc Feldman, M.D., was one of the co-discoverers of anti-TNF as a therapeutic approach to the disease. The translational research center will work in partnership with Novo Nordisk to apply its expertise to the discovery of new treatments.

    “As a translational research center, we are keen to do clinical research on truly innovative ideas that have the potential to improve how patients with autoimmune inflammatory disease are treated today,” professor Feldman remarks. “We will work closely together with Novo Nordisk to apply the most advanced translational research approaches available for discovering new mechanisms and validating drug targets and candidates in autoimmune inflammatory disease in a variety of human disease tissue types and at different stages of disease, to ensure comprehensive characterization of each compound’s clinical potential.”

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »